Skin cancer is the most commonly diagnosed cancer in the United States. Melanoma, a type of skin cancer, makes up a small percentage of these, but it accounts for a majority of skin cancer deaths. Around 73,000 new cases of melanoma will be diagnosed in 2015, according to American Cancer Society estimates. To help promote awareness for Melanoma Monday, here are answers to some frequently asked questions about melanoma.
This year at the San Antonio Breast Cancer Symposium (SABCS) there were two aspects of breast cancer that were clearly emphasized: use of ovarian suppression in premenopausal women with breast cancer and advances in genetic testing for hereditary cancer predisposition.
Results of the SOFT trial (further detailed by Dr. Wade Smith in this post), show a clear benefit to the addition of ovarian suppression in women under the age of 35. This benefit resembles that seen with the addition of Herceptin for HER2+ cancer, and now calls for a change in practice management.